[1]
2017. [Use of Kovaltry® in patients with Hemophilia A: clinical and economical aspects from the pivotal clinical trials]. Farmeconomia. Health economics and therapeutic pathways. 18, 1 (Feb. 2017). DOI:https://doi.org/10.7175/fe.v18i1.1284.